We further observed that XRCC4 loss significantly attenuated cell viability, cisplatin IC50, cell apoptosis, and colony formation in the cisplatin-resistant cell lines treated with cisplatin, confirming the XRCC4 plays an important role in cisplatin resistance in ovarian cancer. Here, XRCC4 is linked to ovarian carcinoma.